As vice president of product strategy and marketing, St John Skilton manages the new product development at Protein Metrics Inc. With deep domain experience in MS and related analytical tools the biopharmaceutical industry, Skilton has been at the forefront of development for many years.
Previously at Danaher, Waters, Micromass and other startups, Skilton has extensive experience in bringing new products to market. His experience in sales, marketing, business development, and analyst roles has helped provide a rounded view of product portfolios and how to deliver tools that are meaningful for customers.
Skilton studied chemical engineering and chemistry at the University of Cape Town, and has a PhD from the University of Fribourg. He has been an author on many papers and with an affinity for languages has lived in the United Kingdom, France, Italy, Switzerland, Japan, the Republic of Korea, and South Africa. When not tinkering with the new tools that Protein Metrics provides, he plays cricket, enjoys snowboarding, does woodwork, and enjoys canoeing with his family.
Contributor: The Biosimilars Wave Is Crashing on the Shores of Biopharma DevelopmentOctober 17th 2022
St John Skilton, PhD, vice president of product strategy and marketing at Protein Metrics, takes a deep dive into how the development of biosimilars is evolving and how tools, such as mass spectrometry, can help companies keep up with advancing technology.